An evidence-based look at what GLP-1 medications like Ozempic do beyond weight loss, from heart and kidney protection to addiction. Current as of June 2026.

Explore how brain insulin resistance may underlie Alzheimer’s, linking metabolic dysfunction to cognitive decline.

Discover the potential of microdosing GLP-1 for weight loss, inflammation, cognitive health, and more.

GLP-1 receptor agonists show promise in Alzheimer’s disease prevention, offering benefits beyond weight loss and diabetes management.

Explore top insights from A4M’s Longevity Conference, including neurotransmitter health, vagus nerve stimulation, GLP-1 therapy, and cellular longevity.